CLVR vs. AMPE, HSTO, PXMD, CALA, EFTR, ONCSQ, ATNFW, LBPSW, AEHAW, and AIMDW
Should you be buying Clever Leaves stock or one of its competitors? The main competitors of Clever Leaves include Ampio Pharmaceuticals (AMPE), Histogen (HSTO), PaxMedica (PXMD), Calithera Biosciences (CALA), eFFECTOR Therapeutics (EFTR), OncoSec Medical (ONCSQ), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), and Ainos (AIMDW). These companies are all part of the "pharmaceutical products" industry.
Clever Leaves vs. Its Competitors
Ampio Pharmaceuticals (NYSE:AMPE) and Clever Leaves (NASDAQ:CLVR) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, risk, analyst recommendations, profitability, valuation and earnings.
Ampio Pharmaceuticals has a beta of 5.09, suggesting that its stock price is 409% more volatile than the S&P 500. Comparatively, Clever Leaves has a beta of 3531.01, suggesting that its stock price is 353,001% more volatile than the S&P 500.
In the previous week, Ampio Pharmaceuticals' average media sentiment score of 0.00 equaled Clever Leaves'average media sentiment score.
Ampio Pharmaceuticals has higher earnings, but lower revenue than Clever Leaves. Ampio Pharmaceuticals is trading at a lower price-to-earnings ratio than Clever Leaves, indicating that it is currently the more affordable of the two stocks.
5.7% of Ampio Pharmaceuticals shares are owned by institutional investors. Comparatively, 6.9% of Clever Leaves shares are owned by institutional investors. 3.3% of Ampio Pharmaceuticals shares are owned by company insiders. Comparatively, 8.2% of Clever Leaves shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Summary
Clever Leaves beats Ampio Pharmaceuticals on 5 of the 7 factors compared between the two stocks.
Get Clever Leaves News Delivered to You Automatically
Sign up to receive the latest news and ratings for CLVR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding CLVR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Clever Leaves Competitors List
Related Companies and Tools
This page (NASDAQ:CLVR) was last updated on 9/12/2025 by MarketBeat.com Staff
Free CLVR Stock Alerts